Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001843872-21-000004
Filing Date
2021-02-22
Accepted
2021-02-22 16:36:41
Documents
2
Period of Report
2021-02-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 2110
2 EDGAR SUPPORTING DOCUMENT powerofattorneyhaas.txt EX-24 3289
  Complete submission text file 0001843872-21-000004.txt   6717
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
Haas Kevin Richard (Reporting) CIK: 0001843872 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26642 | Film No.: 21660863